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Summary
Objective: Apoptosis of chondrocytes plays a pivotal role in cartilage degeneration. Tumor necrosis factor-alpha (TNF-a) is a proinﬂammatory
cytokine and has been assumed to cause the degradation of human cartilage. To investigate the mechanisms of TNF-a-mediated apoptosis of
human chondrocytes from a point of view of the balance between the caspase-cascade and the expression of inhibitor of apoptosis proteins
(IAPs), although both of them are induced with TNF-signals.
Methods: The expression of TNF-receptors (TNF-Rs) in normal human articular chondrocyte (NHAC-kn) was examined with immunocyto-
chemistry. Subconﬂuent cultures of NHAC-kn were tested with TNF-a and/or actinomycin D (actD), and the induction of apoptosis was eval-
uated by the frequency of apoptotic cells visualized with nuclear staining using Hoechst 33342. The activation of caspases and the expression
of IAPs were examined with Western blot analyses.
Results: NHAC-kn expressed TNF-R1 and -R2. When NHAC-kn was treated with TNF-a (10 ng/ml) and actD (0.2 mg/ml) for 24 h, the frequency
of apoptotic cells increased to more than 25%. TNF-a alone, however, induced the apoptosis insufﬁciently (up to 8.3%), even when used at the
concentration of 100 ng/ml for 48 h. In apoptotic human chondrocytes induced with TNF-a (10 ng/ml) and actD (0.2 mg/ml), the caspase-3, -8,
and -9 were activated and the protein expression of XIAP and c-IAP1 decreased.
Conclusions: In apoptotic human chondrocytes induced with TNF-a and actD, the balance between caspase activation and IAPs’ expression
lay with the executioner caspase (caspase-3) and led to decreased expression of XIAP and c-IAP1.
ª 2005 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Apoptosis of chondrocytes plays a pivotal role in cartilage
degeneration. The apoptosis of chondrocytes is observed
in the cartilage of patients of rheumatoid arthritis (RA) and
osteoarthritis (OA)1,2. Various stimuli such as nitric oxide
(NO) and Fas-signals induce the apoptosis in chondro-
cytes3,4. Proinﬂammatory cytokines, such as interleukin-1
(IL-1) and tumor necrosis factor-alpha (TNF-a) have been
assumed to cause the degradation of human cartilage5,6.
TNF-a is a multifunctional cytokine that initiates a wide va-
riety of biological responses, and as one of these functions,
may play a role in the course of apoptosis of chondrocytes.
Nowadays, several anti-TNF-a therapies have been re-
ported to be effective on RA7,8. Although there are a few re-
ports describing TNF-a-mediated apoptosis of human
chondrocyte, the detailed signaling mechanisms are still
unknown9e12.
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2005.435Through binding to the major TNF-receptor (TNF-R), TNF-
R1, TNF-a activates two intracellular signaling pathways.
One is apoptosis pathway involving caspase-cascade, and
the other is anti-apoptosis survival signals, an opposite func-
tion, mediated by nuclear factor-kB (NF-kB)13,14. As the out-
come of opposite signals, many cellular lineages, including
chondrocyte, are resistant to programmed cell deathmediated
by TNF superfamily, including TNF-a, Fas, and TNF-related
apoptosis-inducing ligand (TRAIL)9e12,15e18. These cells,
however, undergo apoptosis in the presence of actinomycin
D (actD), which inhibits DNA-dependent RNA polyme-
rases10,12,15e18. At low concentration (less than 0.1 mg/ml)
actD induces the segregation of the nucleolar components
and impairs r-RNA synthesis, and the treated cells display
the early apoptosis features. When used at high concentra-
tion (more than 1 mg/ml), on the other hand, actD induces
massive apoptosis19. In many cellular lineages except chon-
drocytes, TNF superfamily in combination with actD inhibits
NF-kB activation15, increases the expression of Fas-associ-
ating death domain (FADD)16, and downregulates FADD-
like IL-1 converting enzyme (ICE) (FLICE)-inhibitory protein
(FLIP)17 and survivin expression18. In apoptotic human
chondrocytes induced with TNF-a in combination with
actD, on the other hand, the caspases and c-Jun N-terminal
kinase (JNK) are activated, but the activation of NF-kB is not
inhibited10,12. Furthermore, actD alone does not affect the
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But there are many still unidentiﬁed points about the details
of an apoptosis-related signal.
Nowadays, inhibitor of apoptosis proteins (IAPs) has been
identiﬁed as a new category of regulators of apoptosis. In
1993, the ﬁrst IAP’s family member was identiﬁed in SF21 in-
sect cells20. XIAP is identiﬁed in a search for mammalian
genes homologous to the insect IAPs21, which binds and in-
hibits caspase-3, -7, and -9 with nanomolar afﬁnity, but does
not bind and inhibit caspase-822,23. XIAP also activatesNF-kB
through the phosphorylation and degradation of I-kB24. c-
IAP1 and c-IAP2 are identiﬁed as the proteins interacting
with TNF-R-associated factors (TRAFs), which are signaling
complexes on the cytoplasmic tail of the second TNF-R,
TNF-R225. These two IAPs bind and inhibit caspase-3, -7,
and -9, albeit less strongly than XIAP22. TNF-a-induced
anti-apoptotic signals through both TNF-R1 and TNF-R2 re-
quire the interaction between c-IAPs and TRAFs26,27, and
then, activate NF-kB. Furthermore, the activation of NF-kB
induces expression of XIAP, c-IAP1 and c-IAP226,28. There-
fore, this pathway would work as positive feedback mecha-
nism on the inhibition of TNF-a-induced apoptotic signals.
In the current study, we investigated the mechanisms of
TNF-a-mediated apoptosis of human chondrocytes from
points of view of the expression of TNF-R, the identiﬁcation
of apoptosis by morphologic examination, and the activation
of caspase-cascade. Furthermore, we examined the
change of expression of IAPs in human chondrocytes in
the course of apoptosis induced with the TNF-a and actD.
Materials and methods
CELL CULTURE AND REAGENTS
Normal human articular chondrocyte (NHAC-kn) was pur-
chased from Cambrex (Walkersville, MD). The cells were
cultured in the growth medium speciﬁcally supplied by the
manufacturer. Recombinant human TNF-a was purchased
from Pepro Tech (London, UK). actD was purchased from
SigmaeAldrich (St. Louis, MO).
IMMUNOCYTOCHEMICAL DETECTION OF TNF-R
NHAC-kn was cultured in 2-well Lab-Tek chamber slides
(Nalge Nunc International, Naperville, IL), and ﬁxed in ace-
tone at room temperature for 10 min. Cells were washed
with phosphate-buffered saline (PBS), incubated in 10%nor-
mal horse serum (Vector laboratories Inc., Burlingame, CA)
in PBS at room temperature for 30 min, and then incubated
with primary antibodies at 4(C overnight. Primary antibodies
used in this study were mouse monoclonal anti-human TNF-
R1 (Austral Biologicals, San Ramon, CA) and TNF-R2 (Aus-
tral Biologicals). After washing with PBS, slides were dipped
in 0.3% H2O2 for 30 min, and washed with PBS again, and
cells were incubated with 2% biotinylated anti-mouse-IgG
made in horse (Vector laboratories Inc.) at room tempera-
ture for 30 min. After washing with PBS, cells were further
incubated with ABC kit (Vector laboratories Inc.) at room
temperature for 30 min, and signals were generated with
3,3-diaminobenzidine tetrahydrochloride.
NUCLEAR STAINING WITH HOECHST 33342
Subconﬂuent culture of NHAC-kn in 6-well culture plates
was used. After the treatment with apoptosis-inducingreagents for indicated time periods, Hoechst 33342
(SigmaeAldrich) was added to the culture at the ﬁnal
concentration of 20 mg/ml.
After incubation at 37(C for 30 min, cells were examined
under ﬂuorescence microscopy and fragmented apoptotic
nuclei were identiﬁed. In each preparation, 300 cells were
examined and apoptosis rates were calculated.
IMMUNOBLOT ANALYSIS
Subconﬂuent culture of NHAC-kn in 10 cm culture dishes
was tested with 10 ng/ml of TNF-a and/or 0.2 mg/ml of actD
for 24 h in total. Cells were detached with 0.025% of trypsin
and 0.01% ethylenediaminetetraacetic acid (EDTA),
counted by using trypan-blue dye exclusion, and collected
by centrifugation at 7000 rpm for 5 min. Cells were lysed in
TriseNaCl-EDTA (TNE) buffer [50 mM TriseHCl pH 7.5,
150 mMNaCl, 1 mMEDTA, 50-fold diluted protease inhibitor
cocktail for use with mammalian cells (P8340; Sigmae
Aldrich), 1% Triton X-100], incubated at 4(C for 30 min with
gentle rotation, sonicated, and followed by further incubation
at 4(C for 30 min. The cell lysates were mixed with the equal
volume of 2 Laemmli sample buffer with 2-mercaptoetha-
nol, and boiled for 5 min. Cell lysates were separated in
12% sodium dodecyl sulfate (SDS) polyacrylamide gels
and transferred to polyvinylidene diﬂuoride (PVDF) mem-
branes (Hybond-P; Amersham Biosciences, Buckingham-
shire, UK). After incubation in 5% nonfat dried milk in
Tris-buffered saline (TBS), pH 7.6 containing 0.1% Tween
20 (TBST) at room temperature for 2 h. Membranes were
incubated with primary antibodies at 4(C overnight or at
room temperature for 1 h. Antibody solutions used in this
study were mouse monoclonal antibody to b-actin (Sigmae
Aldrich) and rabbit polyclonal antibody to human c-IAP1
(R&D Systems, Minneapolis, MN) diluted with 5% bovine
serum albumin (Fraction V; SigmaeAldrich) in TBST, and
mouse monoclonal antibodies to human caspase-8 (Cell
Signaling, Beverly, MA) and to human XIAP (BD Bioscien-
ces, San Diego, CA), and rabbit polyclonal antibodies to
human caspase-3, caspase-9 (Cell Signaling) and to human
c-IAP2 (Santa Cruz Biotechnology, Santa Cruz, CA) diluted
with solution-1 (Can get signal; Toyobo, Tokyo, Japan). After
washing with TBST, membranes were incubated at room
temperature for 1 h with horseradish peroxidase (HRP)-
linked F(ab#)2 fragment of anti-mouse immunoglobulins
(Igs) made in sheep (Amersham Biosciences) or with HRP-
linked F(ab#)2 fragment of anti-rabbit Igs made in donkey
(AmershamBiosciences). After washing with TBST and sub-
sequently with TBS, signals were generated with ECL Plus
detection reagents (Amersham Biosciences) by chemilumi-
nescence and exposed at room temperature according to
the protocols suggested by the manufacturer.
Results
EXPRESSION OF TNF-R1 AND TNF-R2 IN CHONDROCYTE
Before investigating the effects of TNF-a on human chon-
drocytes, we examined the expression of TNF-Rs in human
chondrocytes by immunocytochemistry. Figure 1(a and b)
shows the expression of two TNF-Rs, TNF-R1 and TNF-
R2, in cultured human chondrocytes. The receptors are
diffusely expressed in the cytoplasm, which is probably con-
sistent with the localization of membrane receptors. Slides
treated without the primary antibody exhibited no staining
(results not shown).
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When we treated, at ﬁrst, the cultured chondrocytes with
TNF-a alone at the concentration of up to 100 ng/ml for
24 h, the frequency of the cells with apoptosis features
was low, up to 7.0%, and further reached to 8.3% with lon-
ger incubation periods up to 48 h [Figs. 2(a) and 3(a)]. Thus,
this apoptosis-inducing protocol was insufﬁcient for further
biochemical analyses.
Therefore, we tested the combination of TNF-a and actD
as an apoptosis-inducing stimulation. We added actD to the
cell culture, incubated for 2 h, and further added TNF-a10.
After 22 h incubation, 24 h in total as for actD treatment,
the cells were examined for apoptotic features with Hoechst
33342 staining. The apoptosis-promoting effects of actD
were negligible at the concentration of 0.02 mg/ml. The fre-
quency of apoptosis signiﬁcantly increased to more than
25% used at 0.2 mg/ml [Figs. 2(b) and 3(b)]. The cells
were almost completely broken when treated with 2 mg/ml
actD and 10 or 100 ng/ml TNF-a, thus the frequency of ap-
optosis was not exactly calculated. From these results, we
selected the conditions of apoptosis induction, 10 ng/ml of
TNF-a and 0.2 mg/ml of actD for 24 h in total, for the follow-
ing experiments.COMBINATION OF TNF-a AND actD INDUCES CASPASE
CLEAVAGE
Activation of the cascade of caspase proteases is the
major arm of the apoptotic machinery, because caspases
are responsible for cleavage and degradation of important
intracellular proteins. To determine whether the treatment
of chondrocyte with TNF-a and actD causes activation of
caspases, we performed Western blot analyses for the ini-
tiator caspases (caspase-8, -9) and executioner caspase
(caspase-3) using antibodies recognizing both the pro-
form and cleaved forms of these caspases. As shown in
Fig. 4, TNF-a in combination with actD induced the cleav-
age of the 57-kDa procaspase-8 in human chondrocytes,
and increased the accumulation of its cleaved forms of
43-, 41-, and 18-kDa. On the other hand, neither TNF-
a nor actD alone induced the cleavage of procaspase-8.
As for caspase-9, TNF-a in combination with actD induced
the cleavage of the 47-kDa procaspase-9, and we observed
its 37- and 35-kDa cleaved forms. Neither TNF-a nor actD
alone did cause the cleavage of procaspase-9. Further-
more, as for executioner caspase (caspase-3), treatment
with TNF-a in combination with actD causes the cleavage
of the 32-kDa procaspase-3 to its 19- and 17-kDa cleavedFig. 2. Hoechst 33342 staining of chondrocytes incubated with 10 ng/ml of TNF-a (a), and with 10 ng/ml of TNF-a and 0.2 mg/ml of actD (b)
for 24 h. One cell shows chromatin condensation (arrow) (a). Chromatin condensation and fragmentation are visible, indicating deﬁnite
apoptosis (b).
438 F. Yoshimura et al.: IAPs in apoptotic chondrocytesFig. 3. Apoptosis-inducing effect of TNF-a and/or actD on human chondrocytes. Effect of TNF-a alone at different time points (a) and those of
TNF-a in combination with actD at 24 h (b). After the indicated treatment, the cells were stained with Hoechst 33342 and percent apoptotic
cells were calculated as described in Materials and methods. Results were presented as mean s.d. of duplicate wells of three independent
experiments.forms. Neither TNF-a nor actD alone did cause the cleav-
age of procaspase-3.
DECREASED PROTEIN EXPRESSION OF THE IAPS
BY TNF-a IN COMBINATION WITH actD
IAP family proteins play a critical role in the inhibition of
caspase-dependent cell death by binding to caspases.
We examined the alteration of protein expression of the
IAPs’ families during TNF-a-induced apoptosis of human
chondrocyte. The protein expression of the XIAP (57-kDa)
and c-IAP1 (68-kDa) decreased by the 24-h treatment of
TNF-a in combination with actD. TNF-a alone, on the other
hand, slightly upregulated the expression of these two IAPs.
In contrast, the treatment of TNF-a in combination with actD
rather increased c-IAP2 (66-kDa) in human chondrocytes
(Fig. 5).
Discussion
This is the ﬁrst report describing the change of expres-
sion of IAPs in chondrocytes during the course of apoptosis
induced with TNF-a and actD. In combination with actD,
TNF-a-mediated signals decreased the expression of
XIAP and c-IAP1 in human chondrocytes and led to apopto-
sis, while TNF-a-mediated activation of NF-kB signaling in-
creases the expression of IAPs in other cell lineages26,28.Human chondrocytes express TNF-Rs6,29. In previous re-
ports describing TNF-a-mediating apoptosis of chondrocytes,
however, the expression of TNF-Rs is not examined9e12. In
our apoptosis-inducing system, the cultured chondrocytes
clearly expressed TNF-R1 and -R2, and thus, the TNF-a-sig-
naling would be effective in our system.
We examined the activation of initiator caspases (cas-
pase-8, -9) and executioner caspase (caspase-3) by West-
ern blot analyses. Kim and Song reported that the apoptosis
of human chondrocytes is induced through caspase activa-
tion, not inhibition of NF-kB activation by treatment with
TNF-a and actD10. However, this report describes only
the activation of caspase-3. In our current study, we demon-
strated the activation of caspase-3, -8, and -9 during apo-
ptosis induced by TNF-a and actD.
In nonchondrocyte cells, TNF-a signal activates NF-kB,
resulting in the increased expression of IAPs26,28. IAPs
suppress the activation of caspase-3, and lead to the in-
hibition of apoptosis22,23. Activated caspase-3, on the other
hand, degrades XIAP and c-IAP125,30,31. Therefore, the
balance between the activation of caspase-3 and the ex-
pression level of XIAP and c-IAP1 would be a critical
factor determining the fate of cells stimulated with TNF-
a (Fig. 6). In our apoptosis-inducing system using actD,
the balance lay with the activation of caspase-3 and led
to decreased expression of XIAP and c-IAP1 proteins
(Figs. 4 and 5). Since the activation of caspase-3 is
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Fig. 4. Western blot for caspase-8, -9, and -3. Four hundred microliters of cell lysates was prepared from 4 106 cells, and a 30 ml aliquot of
each sample was applied to each wall. After electrophoresis, proteins were transferred to a PVDF membrane, incubated with anti-caspase
antibodies, and visualized as described in Materials and methods. The positions of molecular size markers are indicated (in kDa) on the
left. Chondrocytes treated with TNF-a in combination with actD contain the cleaved form of caspases (arrows). C, medium only; T, TNF-a
(10 ng/ml); A, actD (0.2 mg/ml); T/A, TNF-a (10 ng/ml) and actD (0.2 mg/ml); and Cas, Caspase.C T A T/A
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Fig. 5. Western blot for XIAP, c-IAP1, and c-IAP2. Four hundred mi-
croliters of cell lysates was prepared from 4 106 cells, and a 30 ml
aliquot of each sample was applied to each wall. After electropho-
resis, proteins were transferred to a PVDF membrane, incubated
with anti-caspase antibodies, and visualized as described in Mate-
rials and methods. The amount of XIAP and c-IAP1 in apoptosis-in-
duced chondrocytes decreases, and that of c-IAP2, on the other
hand, rather increases. C, medium only; T, TNF-a (10 ng/ml); A,
actD (0.2 mg/ml); and T/A, TNF-a (10 ng/ml) and actD (0.2 mg/ml).Fig. 6. Schematic diagram of TNF-a-induced apoptotic signals in
human chondrocytes.
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and 6), activation of caspase-8 would be the pivotal event
in the apoptosis induced with additional actD treatment.
Because the caspase-9 was also activated in apoptotic
chondrocytes (Fig. 4), the activation of initiator caspases
would be critical in TNF-a-induced apoptosis of human
chondrocytes. The mechanisms in which actD promotes
the activation of initiator caspases in the presence of
TNF-a are still unknown. In contrast with XIAP and
c-IAP1, the protein expression of c-IAP2 was slightly in-
creased in apoptotic chondrocytes (Fig. 5). The upregula-
tion of c-IAP2 in TNF-a-mediated apoptotic cells was
previously reported in human T-cell line32, however, the
precise mechanisms of this upregulation are still
unknown.
In the patients with RA and OA, the apoptosis of chon-
drocytes is observed in vivo33,34. TNF-a induces the degra-
dation of cartilage in vivo, however, TNF-a alone did not
induce the apoptosis of human chondrocytes in vitro.
Therefore, the inhibition of chondrocyte apoptosis might
not be induced with anti-TNF-a drugs, although the anti-
TNF-a therapy is effective in RA patients. The frequency
of apoptotic chondrocytes in patients received with anti-
TNF-a therapy needs to be examined.
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